期刊文献+

体外受精-胚胎移植中卵巢低反应的治疗进展 被引量:4

Therapy for the Poor Ovarian Responses in IVF-ET
下载PDF
导出
摘要 卵巢低反应是体外受精-胚胎移植(IVF-ET)过程中超促排卵的难题,表现为卵巢在超促排卵中效果不理想,以超促排卵后获卵子数目少和血雌二醇(E2)水平低为特征,常导致患者取消治疗周期,其发生率约占接受IVF治疗妇女的9%~24%。卵巢低反应的机制尚不明确,目前诊断标准不统一。卵巢低反应的原因多种多样,研究人员一直在考虑使用不同的药物和方案改善这部分患者的治疗结局:①增加促性腺激素的用量。②垂体降调节方式。③添加雄激素。④添加生长激素。⑤采用自然周期或微刺激方案。⑥使用口服避孕药、雌激素。尽管处理不良反应的方法很多,但目前仍缺乏能有效逆转卵巢对超促排卵反应不良的方法,采用一种适合的个体化方案可能是在这种困境当中的唯一选择。 The poor ovarian response,a problem of controlled ovarian hyperstimulation in IVF-ET,is characteristic of the poor outcome of ovarian hyperstimulation failure,the limited number of recruit follicles,and lower E2 level,which often leads to the cycle cancel of IVF-ET.The incidence of poor response in IVF-ET is 9% to 24%.The mechanism of poor ovarian response is not well clarified;even the diagnosis standard is skimble-scamble.Various treatment protocols were proposed to improve the ovarian reactivity of patients with the poor ovarian response.These protocols were listed as follows:① Increasing the stimulation dose of rFSH.② Pituitary down regulation.③ The use of androgens or androgen-modulating agents.④ Administration of growth hormone.⑤ Modified natural cycle IVF.⑥ Adjuvant therapy such as the use of oral contraceptive pill(COCP),E2.There is little understanding which one is the best protocol to treat effectively the poor ovarian response.It could be a feasible choice for different individual to have a suitable and personalized protocol.
出处 《国际生殖健康/计划生育杂志》 CAS 2012年第5期405-407,共3页 Journal of International Reproductive Health/Family Planning
基金 天津市卫生局科技基金(2010KZ113)
关键词 受精 体外 胚胎移植 生殖技术 辅助 卵巢功能早衰 Fertilization in Vitro; Embryo transfer; Reproductive techniques,assisted; Ovarian failure,premature
  • 相关文献

参考文献20

  • 1Padhy N,Gupta S,Mahla A,et al. Demographic characteristics and clinical profile of poor responders in IVF/ICSI:A comparative study [J]. J Hum Reprod Sci, 2010,3 (2) : 91-94.
  • 2Coccia ME,Rizzello F,Mariani G,et al. Impact of endometriosis on in vitro fertilization and embryo transfer cycles in young women:a stage-dependent interference [J]. Acta Obstet Gynecol Scand, 2011,90( 11 ) : 1232-1238.
  • 3Sheikhha MH,Eftekhar M,Kalantar SM. Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation [J]. J Hum Reprod Sci ,2011,4(2):86-90.
  • 4Pires ES, Parikh FR, Mande PV, et al. Can anti-ovarian antibody testing be useful in an IVF-ET clinic? [J]. J Assist Reprod Genet, 2011,28( 1 ) :55-64.
  • 5Grzegorczyk-Martin V, Khrouf M, Bringer-Deutsch S, et al. Low circulating anti -Mtillerian hormone and normal follicle stimulating hormone levels :Which prognosis in an IVF program? [J]. Gynecol Obstet Fertil, 2012,40(7/8 ) : 411-418.
  • 6Choi MH,Yoo JH,Kim HO,et al. Serum anti-Mtillerian hormone levels as a predictor of the ovarian response and IVF outcomes [J]. Clin Exp Reprod Med, 2011,38 (3) : 153-158.
  • 7Tutuncu L, Dundar O. Increasing the stimulation dose of rFSH in unexpected poor responders is not associated with better IVF outcome [J]. Ginekol Pol, 2012,83(2) : 111-115.
  • 8Kim CH,You RM,Kang HJ,et al. GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSI [J]. Clin Exp Reprod Med, 2011,38 (4) : 228-233.
  • 9Madani T,Ashrafi M,Yeganeh LM. Comparison of different stimulation protocols efficacy in poor responders undergoing IVF:a retrospective study [J]. Gynecol Endocrinol, 2012,28 (2) : 102-105.
  • 10Pu D,Wu J,Liu J. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF [J]. Hum Reprod, 2011,26(10) : 2742-2749.

同被引文献34

  • 1Loutradis D, Drakakis P, Milingos S, et al.Alternative approaches in the management of poor response in controlled ovarian hyperstimulation (COH)[ J ] .Ann N Y Acad Sci,2003,9"7: 112-119.
  • 2Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE consensus on the definition of "poor response" to ovarian stimulation for in vitro fertilization: the Bologna eriteria[J ] .Hum Reprod ,2011, 26: 1616-1624.
  • 3国家中医药管理局.中医临床诊疗术语证候部分[S].北京:中国标准出版社,2004:5-24.
  • 4Van Noord-Zaadstra BM, Looman CW, Alsbach H, et al. Delaying childbearing : effect of age on fecundity and outcome of pregnancy[ J ]. BMJ, 1991, 302 ( 6789 ) : 1361-1365.
  • 5La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers : from theory to practice [J]. Hum Reprod Update, 2013, 20 ( 1 ) : 124-140.
  • 6Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization : the Bologna criteria [ J ] . Hum Reprod, 2011, 26 ( 7 ): 1616-1624.
  • 7Maheshwari A, Gibreel A, Siristatidis CS, et al. Gonadotrophin- releasing hormone agonist protocols for pituitary suppression in assisted reproduction[ J ]. Cochrane Database Syst Rev, 2011, 66( 8 ): C D006919.
  • 8Tutuncu L, Dundar O. Increasing the stimulation dose of rFHS in unexpected poor responders is not associated with better IVF outcome I J ] ~ Ginekol Pol, 2012, 83 ( 2 ) : 111-115.
  • 9Muasher SJ, Abdallah RT, Hubayter ZR. Optimal stimulation protocols for in vitro fertilization[J].Fertil Steril, 2006, 86 ( 2 ) : 267-273.
  • 10Sbracia M, Farina A, Poverini R, et al. Short versus long gonadotropin-releasing hormone analogue suppression protocols for superovulation in patients > or = 40 years old undergoing intracytoplasmic sperm injection I J 1 ~ Fertil Steril, 2005, 84 ( 3 ) : 644-648.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部